Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Nancy Mckinstry is Director at Accenture. OQRO lists 11 transactions filed with the SEC under this name, the latest on Nov 12, 2026, each linked to the official Form 4.
Director
Photo: Dennis912, CC BY-SA 3.0. Original file
Disclosures on record
11
Companies involved
4
Nancy Mckinstry has no open-market purchase on record since 2022. Sales in 1 of the 5 years since 2022.
Nancy Mckinstry reported 0 open-market purchases and 1 sale since 2022; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2022 | — | $188K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Nov 11, 20261,224disclosed Nov 12
DetailsOfficial recordAccentureACN
7 disclosures · Nov 2025 – Aug 2026
Aug 14, 202612disclosed Aug 18
DetailsOfficial recordMay 15, 202612disclosed May 19
DetailsOfficial recordFeb 13, 20267disclosed Feb 18
DetailsOfficial recordFeb 13, 20264disclosed Feb 18
DetailsOfficial recordFeb 6, 2026398disclosed Feb 10
DetailsOfficial recordJan 28, 20261,212disclosed Jan 30
DetailsOfficial recordNov 14, 20256disclosed Nov 19
DetailsOfficial recordMay 20, 20263,525disclosed May 21
DetailsOfficial recordAbbott LaboratoriesABT
2 disclosures · Apr 2026
Apr 24, 20262,286disclosed Apr 28
DetailsOfficial recordApr 24, 20262,305disclosed Apr 28
DetailsOfficial recordAs of the latest filing on , Nancy Mckinstry reported holding 41,010 shares of Abbott Laboratories (ABT), worth about $4.45M at the last close of $109 (Nov 13, 2026). Holdings are also on file at Accenture (ACN), Mondelez International (MDLZ), Automatic Data Processing (ADP); together they are worth about $7.31M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Abbott Laboratories ABT | 41,010 | 41K direct | $109 | $4.45M | Apr 24, 2026 |
| Accenture ACN | 8,107 | 8,107 direct | $250 | $2.03M | Aug 14, 2026 |
| Mondelez International MDLZ | 6,634 | 6,634 direct | $68 | $448K | May 20, 2026 |
| Automatic Data Processing ADP | 1,224 | 1,224 direct | $310 | $379K | Nov 11, 2026 |
Is this Nancy Mckinstry’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Nancy Mckinstry reported 0 open-market purchases and 1 sale here, 2022.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Apr 24, 2026, Nancy Mckinstry reported holding 41,010 shares of Abbott Laboratories (ABT). At the last close of $109 on Nov 13, 2026, that is about $4.45M. This is the stake disclosed in filings, not a net worth.
Nancy Mckinstry has no open-market purchase on record since 2022. Sales in 1 of the 5 years since 2022.
In SEC filings since 2022: no open-market purchase is on record; the latest open-market sale is from 2022.
Abbott Laboratories (ABT), from 2022 to 2022: 0 purchases and 1 sale.
